0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Proximal Lower-Limb Weakness in Charcot-Marie-Tooth Disease

José Berciano, MD1; Elena Gallardo, MD2
[+] Author Affiliations
1Services of Neurology, University Hospital Marqués de Valdecilla (IFIMAV), University of Cantabria, and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
2Services of Radiology, University Hospital Marqués de Valdecilla (IFIMAV), University of Cantabria, and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Santander, Spain
JAMA Neurol. 2013;70(12):1587. doi:10.1001/jamaneurol.2013.4662.
Text Size: A A A
Published online

Extract

To the Editor We read with interest the article by Lee et al1 describing hereditary motor and sensory neuropathy with proximal dominance, a rare type of autosomal dominant adult-onset Charcot-Marie-Tooth disease (CMT). It is indicated that detailed magnetic resonance imaging analysis revealed a distinct pattern of muscular involvement consisting of marked hyperintense signal changes in the hip muscles compared with those in the thigh or the leg muscles. According to the authors, these signal changes are different from the ones in patients with CMT with length-dependent neuropathy.2,3 Although accepting this position, we wish to draw attention to the fact that, late in the clinical course, a small subset of patients with CMT type 1A (CMT1A), the most common form of CMT, may exhibit florid involvement of thigh and pelvic musculature.4,5 One of our patients with CMT1A, aged 53 years, was serially evaluated over 3 decades. Initial examination at age 23 years showed mild phenotype including pes cavus, areflexia, stocking hypoesthesia, and nerve enlargement.4 At age 34 years and throughout the subsequent 4 years, she developed gradually progressive and symmetric leg amyotrophy and weakness, obliging her to use foot orthotics. As of age 43 years, she developed progressive deterioration of gait, her walk becoming ungainly and waddling with bilateral steppage obliging her to continuously use a cane. At her last examination, her stance was wide based and also possible only with support (see Figure 1 in the article by Berciano et al4), and there was positive Gowers maneuver in getting up from a chair. At that time, magnetic resonance imaging of the pelvic, thigh, and calf musculature showed extensive fatty muscle atrophy comparable with that illustrated by Lee et al1 (Figure 2I-P). Worthy of note is the fact that marked fatty atrophy of gluteus medius and minimus muscles was an outstanding finding in both studies,1,4 accounting for the observed waddling gait. In short, involvement of pelvic and thigh musculature, which is a characteristically inaugural manifestation of hereditary motor and sensory neuropathy with proximal dominance, may exceptionally occur late in the clinical course of CMT1A.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

December 1, 2013
Ki Wha Chung, PhD; Sang Soo Lee, MD; Young Bin Hong, PhD; Jeong Hyun Yoo, MD; Byung-Ok Choi, MD
1Department of Biological Science, Kongju National University, Gongju, Korea
2Department of Neurology, Chungbuk National University School of Medicine, Chungbuk, Korea
3Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
4Department of Radiology, Ewha Womans University School of Medicine, Seoul, Korea
JAMA Neurol. 2013;70(12):1587-1588. doi:10.1001/jamaneurol.2013.4770.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

234 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();